Joe Rogan Says He Went to White House to Push Donald Trump on Ibogaine
The podcaster gave no date for the visit, but the drug he says helped veterans when 'nothing worked' still carries a cardiac warning.

Joe Rogan says he went to the White House to push President Donald Trump on ibogaine, the psychedelic that a group of conservatives and veterans' advocates want approved to treat addiction and combat trauma.
Rogan made the remarks on an episode of The Joe Rogan Experience with actor Gary Sinise. He described the push as an "ibogaine initiative" run by former Texas Governor Rick Perry and Bryan Hubbard, and said the drug had helped veterans that other treatments failed.
What Joe Rogan Said About Ibogaine and Donald Trump
The subject came up when Rogan asked Sinise, who has run a veterans' charity since 2011, whether he knew Marcus Luttrell, the former Navy SEAL.
"He's involved in this ibogaine initiative that they're pushing through with Rick Perry and Bryan Hubbard. It's a really amazing thing," Rogan said. "This is one of the things that I went to the White House to talk to Trump about, about pushing it through, about getting that."
He said the drug has "helped them deal with their demons, helped them overcome alcoholism and addiction to pills," adding: "I know so many people that have come back from that and had just ... Nothing helps. Nothing worked until they did that."
Rogan did not say when the visit took place or what Trump told him. He was in the Oval Office on April 18, along with Luttrell, when Trump signed an executive order to speed federal review of psychedelics, PBS NewsHour reported. At that ceremony Rogan said he had sent Trump information about ibogaine, Stars and Stripes reported.
Rogan is not breaking with the president here. On ibogaine, he and Trump are on the same side.
Where Ibogaine Policy Stands
The April order, titled "Accelerating Medical Treatments for Serious Mental Illness," tells the Food and Drug Administration to speed its review of some psychedelic therapies. It also directs the Department of Health and Human Services to send at least $50 million to states with psychedelic programs. It did not change ibogaine's legal status: the drug is still in Schedule I, the most restrictive federal category. HHS and the FDA were told to work with the Department of Veterans Affairs and private companies to get more patients into clinical trials. The White House framed the order around veterans and their high suicide rates.
Texas moved first. In 2025 the Legislature passed Senate Bill 2308, which approved $50 million for ibogaine trials aimed at FDA approval. Under the law, the state gets at least 20 percent of revenue from any approved drug, and a quarter of that goes to a veterans' fund, the Texas Tribune reported. The law was meant to pair the state with a drug company. But the proposals companies submitted did not meet its requirements, which included matching the $50 million. On March 31, Lt. Gov. Dan Patrick and House Speaker Dustin Burrows announced that Texas would run its own research program with UTHealth Houston and the University of Texas Medical Branch.
Key steps so far:
- 2025: Texas enacts SB 2308, which approves $50 million for ibogaine trials.
- March 31, 2026: Texas leaders say the state will run the research itself.
- April 18, 2026: Trump signs the psychedelics order, with Rogan and Luttrell in attendance.
- Date not given: Rogan's White House visit to talk to Trump about ibogaine, by his own account.
Who Is Behind the Push
Perry served as energy secretary in Trump's first term. Luttrell, a friend of his since 2006, told him he planned to go to Mexico for ibogaine treatment, and Perry was skeptical at first, the Tribune reported. Hubbard is CEO of the advocacy group Americans for Ibogaine.
What the Evidence Shows
The drug's risks are well documented. Ibogaine can cause irregular heart rhythms and has been linked to more than 30 deaths in the medical literature. The National Institutes of Health stopped its own research on the drug in the 1990s over "cardiovascular toxicity," PBS NewsHour reported. Hubbard has said Texas is probably at least six years from FDA movement.
Later in the episode, Rogan read out figures on veteran suicides, calling it "roughly four to one." He said a university Costs of War study estimated 30,177 deaths by suicide among post-9/11 service members and veterans, against 7,057 U.S. military deaths in post-9/11 war operations.
How quickly any of this reaches veterans now depends on federal regulators and the Texas trials, not on a podcast.
Sources
- Trump signs order to hasten review of psychedelics — Rogan and Luttrell at the April 18 signing; $50M to states; Schedule I status; cardiac risks and 30+ deaths; NIH halted 1990s research
- Trump advances psychedelic review, joined by ex-SEALs — Order title, FDA/HHS/VA trial directive, Rogan said he sent Trump ibogaine information
- President Trump's Landmark Order Advances Breakthrough Mental Health Treatments — White House framing of the order around veterans
2 more sources
- Texas to conduct its own ibogaine clinical trials — March 31 announcement, SB 2308, failed company bids, UTHealth/UTMB, Hubbard as CEO of Americans for Ibogaine
- With Rick Perry's backing and $50 million from the state, Texas set to become a leader in psychedelics research — Perry's role, Luttrell backstory, $50 million approved, 20% revenue share, Hubbard's six-year estimate